| Jennifer Ui, MD | |
|
35734 Bentley Dr, Avon, OH 44011-3812 | |
| (440) 937-0381 | |
| Not Available |
| Full Name | Jennifer Ui |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 24 Years |
| Location | 35734 Bentley Dr, Avon, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225207194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0008X | Psychiatry & Neurology - Neuromuscular Medicine | 90811 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Fairview Hospital | Cleveland, OH | Hospital |
| Medina Hospital | Medina, OH | Hospital |
| Cleveland Clinic Avon Hospital | Avon, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
A new gait-stabilizing device called the Yaktrax Walker has shown to reduce the risk of injurious falls during winter months in older adults who are fall-prone, reports a study in the Journal of the American Geriatrics Society.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
Targeted Genetics Corporation (the "Company") today announced that it has determined that the expense and management attention required for NASDAQ Capital Market and Securities and Exchange Commission ("SEC") compliance outweigh the benefits for the Company and its shareholders at this time.
A team at the University of Kansas School of Medicine has identified a potential target for treating breast cancer, including a particularly deadly form of the disease.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
› Verified 8 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
A new gait-stabilizing device called the Yaktrax Walker has shown to reduce the risk of injurious falls during winter months in older adults who are fall-prone, reports a study in the Journal of the American Geriatrics Society.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
Targeted Genetics Corporation (the "Company") today announced that it has determined that the expense and management attention required for NASDAQ Capital Market and Securities and Exchange Commission ("SEC") compliance outweigh the benefits for the Company and its shareholders at this time.
A team at the University of Kansas School of Medicine has identified a potential target for treating breast cancer, including a particularly deadly form of the disease.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ui, MD 9500 Euclid Ave, S90, Cleveland, OH 44195-0001 Ph: (216) 444-8370 | Jennifer Ui, MD 35734 Bentley Dr, Avon, OH 44011-3812 Ph: (440) 937-0381 |
News Archive
A new gait-stabilizing device called the Yaktrax Walker has shown to reduce the risk of injurious falls during winter months in older adults who are fall-prone, reports a study in the Journal of the American Geriatrics Society.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
Targeted Genetics Corporation (the "Company") today announced that it has determined that the expense and management attention required for NASDAQ Capital Market and Securities and Exchange Commission ("SEC") compliance outweigh the benefits for the Company and its shareholders at this time.
A team at the University of Kansas School of Medicine has identified a potential target for treating breast cancer, including a particularly deadly form of the disease.
MedCath Corporation announced today the completion of the sale of substantially all the assets of TexSan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction, which was announced in November, and was subject to customary closing conditions and regulatory requirements, was completed effective December 31, 2010.
› Verified 8 days ago